Brain signalling
Helps regulate hunger and satiety, reducing appetite and food intake.


Start with the reason for treatment, not just the brand name. Tell the doctor whether you are exploring weight management or continuing diabetes care, and bring the exact name of any current product.

Semaglutide for weight management alongside nutrition and physical activity, subject to the product’s eligibility criteria.
Read the relevant guide
A semaglutide injection for type 2 diabetes; it is not treated here as a routine substitute for the weight-management pathway.
Read the relevant guide
Rybelsus is an oral semaglutide diabetes medicine. Oral and injectable products are not interchangeable milligram for milligram.
Read the relevant guideClinical references: EMA: Wegovy · EMA: Ozempic · EMA: Rybelsus
Semaglutide is a GLP-1 receptor agonist. It mimics signalling by the natural incretin hormone GLP-1, with effects on appetite and blood-glucose regulation.
Helps regulate hunger and satiety, reducing appetite and food intake.
Supports glucose-dependent insulin release. Treatment effects and safety still require individual review.
| Question | What matters for your review |
|---|---|
| What does it do? | Semaglutide acts at the GLP-1 receptor, affecting appetite and blood-glucose regulation. |
| Which formulation? | The clinician checks the particular product and authorised indication, not simply “semaglutide”. |
| Can I change products? | A change needs an individual plan; do not substitute pens, tablets or doses yourself. |
| Are new products available here? | EU authorisation and actual availability in Spanish pharmacies are different checks. No launch date or local stock is promised. |
Book the relevant medical assessment; the optional pre-check is not a prescription decision.
Discuss your history, medicines and the evidence needed to make a safe plan.
Receive advice, any onward-care recommendation and an e-prescription only if appropriate.
Use a participating pharmacy and follow the agreed review plan. Medicine cost is separate.
For a Málaga stay, bring the original box or a clear named prescription: a brand familiar in another country may not identify the same Spanish presentation. Use Málaga capital in the provincial pharmacy finder; confirm the formulation and strength before travelling from the centre, Teatinos or the eastern coast.
Appointments are provided remotely. Our physical clinic is in Nerja; this page does not claim a Málaga city branch. Local examination or tests may be recommended when needed.

Semaglutide is the ingredient. Wegovy is one brand containing it; Ozempic and Rybelsus have their own formulations and authorised uses.
You can request an English-speaking assessment. The doctor may need records, tests or examination before a treatment decision.
No. The weight-management pre-check is only a preliminary screen. Diabetes treatment requires its own clinical review.
Do not make this change yourself. The doctor must confirm the product, reason for treatment and transition plan.
The national guide should separate published evidence, regulatory approval and verified Spanish availability. A development is not a promise that a pharmacy can supply it.
If prescribed, present the electronic prescription at a participating pharmacy. Confirm the exact product and stock directly.
Use the official provincial duty-pharmacy finder. Choose Málaga and the appropriate district or municipality and date; it does not guarantee medicine stock.
Open the official Málaga pharmacy finder ↗Read the national treatment guide or find a general doctor service near where you are staying.
Severe persistent abdominal pain or repeated vomiting needs urgent assessment. Call 112 for collapse, serious breathing difficulty or a severe allergic reaction.